baber/WOPTO huggingface dataset:
Patent CA-2447085-A1 (CA)
Title: Procede d'extraction de gluten contenu dans des aliments ayant subi ou non un traitement thermique, compatible avec un dosage immunoenzymatique (elisa), composition et necessaires renfermant ladite composition
Inventor: MENDEZ CORMAN ENRIQUE
IPC: G01N33/02
Filed: 2002-05-03
Abstract: La présente invention concerne un procédé destiné à l'extraction du gluten contenu dans un échantillon, consistant à utiliser une solution aqueuse d'éthanol en présence d'une composition renfermant un agent réducteur de groupes disulfure et un agent de dissociation, dans une solution tampon ayant un pH compris entre 7 et 8. Ce procédé permet d'extraire quantitativement le gluten contenu dans un échantillon d'aliment ayant subi ou non un traitement thermique, avant la quantification du gluten par dosage immunoenzymatique (ELISA). Ce procédé s'applique à l'analyse d'aliments et en particulier à l'analyse d'aliments destinés aux malades coeliaques.
Patent CA-2449147-A1 (CA)
Title: Intake air flow control system for internal combustion engine
Inventor: TSUYUGUCHI MAKOTO
IPC: F02D31/00
Filed: 2003-11-13
Abstract: To provide an intake air flow control system for an internal combustion engine with which it is possible to prevent a rise in cost and to prevent adverse effects on the starting characteristics of the internal combustion engine. At the time of performing a reference position adjustment of an auxiliary intake air flow control valve, when both a first re-reading condition where the absolute value of the difference between a target idling engine speed and a current idling engine speed is smaller than a first threshold and a second re-reading condition where the absolute value of the difference between a calculated intake flow rate and a reference intake flow rate is greater than a second threshold are established, step S5 is performed in which a valve opening corresponding to the reference intake flow rate on a reference characteristic basis is used in place of a valve opening corresponding to the calculated intake flow rate.
Patent CA-2449695-A1 (CA)
Title: Furnace and steam reforming process
Inventor: HILTON MICHAEL
IPC: B01J8/06
Filed: 2002-06-05
Abstract: A steam reforming furnace (F) has a plurality of substantially vertical reformer tubes (T). Each reformer tube (T) has a feed inlet (P) at its lower end, and outlet at its upper end, and a catalyst containment zone disposed intermediate its upper and lower ends and contains a charge of a particulate steam reforming catalyst (C) which is insufficient to fill completely the catalyst containment zone. An upper retainer means (3) is mounted at the upper end of the catalyst containment zone and is permeable to gas or vapour but retains particles of the catalyst (C) in the catalyst containment zone. A  follower means (4; 24) is movably mounted in the catalyst containment zone beneath the charge catalyst (C) for movement upwardly from a lower end of the containment zone upon upward flow of gas through the catalyst containment zone at a rate beyond a threshold rate. A reactant mixture comprising the hydrocarbon feedstock and steam flows upwardly through each reformer tube (T) at a flow rate which is sufficient to cause the catalyst (C) in each reformer tube (T) to rise up and form a cushion of catalyst (C) against the underside of the upper retainer means (3) in its reformer tube (T) and which is in excess of the threshold rate so as to cause the follower means (4; 24) in the reformer tube (T) to move upwardly until it abuts against the underside of the cushion of catalyst (C) in its reformer tube (T). The reformer tubes (T) are heated externally by means of the steam reformer furnace (F) so as to maintain steam reforming conditions in each of the plurality of reformer tubes (T) and covert the hydrocarbon feedstock by reaction with steam to form a reformed gas mixture comprising carbon oxides and hydrogen.
Patent CA-2451280-A1 (CA)
Title: Composition catalysante a tamis moleculaire, methode de production et d'utilisation dans des procedes de conversion
Inventor: CHANG YUN-FENG
IPC: B01J37/04
Filed: 2002-06-24
Abstract: L'invention concerne une composition catalysante à tamis moléculaire, une méthode de préparation et de production de la composition catalysante à tamis moléculaire, et une méthode utilisant la composition catalysante. L'invention concerne en particulier une méthode de production d'une composition catalysante à tamis moléculaire, qui consiste à former une suspension en combinant un tamis moléculaire, un liant et un matériel de base, la suspension présentant un pH supérieur ou inférieur au point isoélectrique du tamis moléculaire. La composition catalysante présente une résistance à l'usure améliorée, particulièrement utile dans un procédé de conversion destiné à produire une (des) oléfine(s), de préférence de l'éthylène et/ou du propylène, à partir d'une charge de départ, de préférence une charge de départ contenant un composé oxygéné.
Patent CA-2451765-A1 (CA)
Title: Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
Inventor: COMARATTA LEONARD M
IPC: C07K14/495
Filed: 2002-06-05
Abstract: This invention describes a novel method of producing bioactive recombinant proteins from plants. General methods of designing and engineering plants for expression and production of such proteins are also disclosed. Methods for the expression of Transforming Growth Factor-B (TGF-B) proteins, such as Müllerian Inhibiting Substance (MIS), in plants, and methods of producing recombinant proteins from plants are specifically disclosed. Furthermore, the present invention provides methodology for the direct expression and production of a bioactive C-terminal fragment of a TGF-B protein, such as C-terminal MIS. The new method is more cost-effective than other large-scale expression systems, by eliminating the need for costly cell culture and fermentation manufacturing facilities.
Patent CA-2452646-A1 (CA)
Title: Derivatives of aryl(or heteroaryl) azolylcarbinols for the treatement ofurinary incontinence
Inventor: MERCE-VIDAL RAMON
IPC: A61K31/4155
Filed: 2002-07-01
Abstract: The invention relates to aryl (or heteroaryl) azolylcarbynol derivatives having general formula (I), wherein: Ar represents an optionally substituted phenyl radical or thienyl radical; R1191 represents a hydrogen atom or a lower alkyl group; R2191 represents a dialkylaminoalkyl or azaheterocycloalkyl radical; and Het represents a non-substituted azole or an azole optionally substituted by one or two substituents. The invention also relates to the physiologically-acceptable salts of said derivatives. The inventive derivatives can be used as medicaments in human and/or veterinary therapy for the treatment of urinary incontinence in mammals, including humans.
Patent CA-2453134-A1 (CA)
Title: Method and device for coating pharmaceutical products
Inventor: STROM DANIEL
IPC: B05D1/26
Filed: 2002-07-09
Abstract: The present invention relates to a method for coating of a pharmaceutical product. The method comprises the step of producing discrete droplets (7) of controlled size, shape and composition with at least one micro dispenser (1) and distributing droplets (7) with controlled velocity, time of flight. Also, the method comprises the step of controlling the production frequency and modulation of the droplets (7). Further, the method comprises the step of controlling the flow rate, temperature and composition of the carrier gas and directing droplets (7) towards particles (10) subjected to coating.The present invention also relates to a device for coating of a pharmaceutical product.  The device comprises a droplet producing unit (1) and a droplet-directing unit (8). The droplet producing unit (1) is a piezo-actuated micro dispenser (1) for producing discrete droplets (7) and controlling the size, shape and composition of said droplets (7).
Patent CA-2455341-A1 (CA)
Title: Nouveau ligand pour recepteurs nicotiniques de l'acetylcholine utilises en therapie
Inventor: PHILLIPS EIFION
IPC: A61P1/04
Filed: 2002-05-29
Abstract: L'invention concerne un composé de formule (I) et ses sels pharmaceutiquement acceptables ainsi que leurs utilisations en thérapie et des compositions renfermant lesdits sels et composés.
Patent CA-2455801-A1 (CA)
Inventor: GREENE BRIAN
IPC: A01K23/00
Filed: 2004-01-21
Abstract: The bag has a pouch made up of walls which are attached to adjacent walls by fold lines. The walls open to admit excrement and close to confine the excrement within the pouch. A front wall of the pouch has a flap which pivots from a closed position in which the outer surface of the flap is adjacent to the front wall and an open position in which the flap is generally co-planar with the outer wall. A pocket is formed on the outer surface of the flap for receipt of the blade of a spatula or a screw driver. The bag includes an enclosure within which the pouch is confined when it contains excrement. The enclosure has a central segment which is attached to the pouch and a pair of outer segments which are attached to opposite sides of the central segment by fold lines and which fold over the pouch in order to prevent excrement from accidentally discharging from the pouch.
Patent CA-2455857-A1 (CA)
Inventor: COLLET DANIEL
IPC: G06F21/00
Filed: 2002-07-22
Abstract: Le but de la présente invention consisté à échanger des données entre plusieurs ordinateurs ou unités multimédias à travers un réseau public tout en garantissant la confidentialité de ces données. Ce but est atteint par une méthode de création et d'exploitation d'un réseau privé virtuel (VPN) comprenant une pluralité d'unités connectées à un réseau public, chaque unité comprenant des moyens de sécurité disposant d'un numéro unique UA1, cette méthode étant caractérisée par les étapes suivantes: générer par les moyens de sécurité d'une unité U1, un droit D1 associé au numéro unique UA1, transférer ce droit D1 aux moyens de sécurité d'au moins une unité U2, encrypter les données envoyées par l'unité U1 et la description du droit D1 par une première clé K1, recevoir les données encryptées par la seconde unité U2, présente ces données aux moyens de sécurité de l'unité U2, vérifier si les droits D1 sont présents et dans l'affirmative, décrypter les données.
Patent CA-2460599-A1 (CA)
Title: Monitoring device
Inventor: MCDONALD ANDREW
IPC: H04W4/02
Filed: 2004-03-10
Abstract: The present invention includes a mobile telephone having a radio transmit/receive function, and a control unit 109 that detects key input operations by a user, and has the mobile telephone transmit an emergency notification message to a predetermined address stored in a storage unit 112 when notified by a timer unit 111 that a preset period has elapsed since a key input operation was last detected.
Patent CA-2460761-A1 (CA)
Inventor: CYR MAURICE
IPC: F42B6/06
Filed: 2004-03-11
Abstract: A detachable nock for use with a bow hunting arrow, said arrow having a locating device associated with and transported by it. The detachable nock engages with the target animal and separates the locating device from the arrow as the arrow passes through the target animal, thereby retaining the locating device with the animal to permit tracking. The detachable nock may be constructed with various fixed or movable retention components to accommodate the needs of a wide range of hunters. The design of the detachable nock minimizes its impact on the flight of the arrow and allows the bow hunter to use any style of hollow-shaft arrow, broadhead, and fletching.
Patent CA-2460816-A1 (CA)
Inventor: GULIKOV ALEXEE A
IPC: E04C5/06
Filed: 2002-08-02
Abstract: A SpiralNet device is disclosed. The device is consisted by its number of spiraled bends according to request geometric shape of a concrete column, where Figure 1 shows a SpiralNet for a rectangular shape frame of a concrete column. The spiraled bends are starting from point 1 to point 2 with 135 degree, and continuously followed by 90 degree spiraled bends from point 2 to point 3 along a side of a concrete column, and from point 3 to point 4 along an adjacent side of the same column, and from point 4 to point 5 the next adjacent side of the same column, and from point 5 to point 6 the continuous adjacent side of the same column, and then finished with the last 135 degree spiraled bend from point 6 to point 7. The measurement of bends are according to any section view which is perpendicular to all edges. The device can be used to construct any shape of concrete column by assembling SpiralNet in a unique order.
Patent CA-2461165-A1 (CA)
Inventor: HUNDERTMARK JAMES M
IPC: B63H25/22
Filed: 2002-09-27
Abstract: A power steering system (10) for a watercraft comprises a hydraulically actuated, unbalanced steering cylinder assembly (32), a pressure source (30) , and helm (26) that is spaced from the steering cylinder assembly (32). The helm (26) includes a helm cylinder (70) having a slave chamber (98) luidical ly coupled to a second chamber (56) in the steering cylinder (50), a high pressure port fluidically coupled to the outlet of the pressure source and t o a first chamber (54) in the steering cylinder (50), and a return port (88) fluidic ally coupled to vent. A helm piston (92) is slidably mounted in the helm cylinder (70), and a control valve assembly (90) is movable between at least first and second positions to alternatively couple a control chamber (100) in the helm cylinder (70) to the high pressure and return ports. In order to facilitate mounting of the helm (26) to the dash (22) of the watercraft, the helm (26) has only three ports, and all three ports are all located on a rear axial end of the helm cylinder (70). The helm cylinder (70 ) also is very compact, having a diameter of no more than about +3".
Patent CA-2463379-A1 (CA)
Inventor: TAPUSKA DAVID F
IPC: G06F21/34
Filed: 2004-04-07
Abstract: Systems and methods are provided for facilitating access to an electronic device. Password information is stored on the electronic device, and on a portable authenticator. W hen a user attempts to access the electronic device, the user is prompted to enter a password at the electronic device. The portable authenticator determines the validity of the entered password. The electronic device receives the results of the validity determination from the portable authenticator, and provides access to the electronic device based on the received validity determination.
Patent CA-2465989-A1 (CA)
Inventor: HISAMURA KOJI
IPC: B01D11/04
Filed: 2002-09-26
Abstract: The following [1] to [3], etc. 1,3-Butylene glycol which, upon analysis by g as chromatography under specific conditions, gives a chromatogram in which the sum of the areas of the peaks appearing in a specific range of relative retention time accounts for 0.025% or less of the area of the peak for 1,3- butylene glycol. 1,3-Butylene glycol which, upon analysis by gas chromatography under specific conditions, gives a chromatogram in which the sum of the areas of the peaks attributable to compounds having a hydroxy gro up and an ether bond and having a molecular weight of 188 accounts for 0.025% o r less of the area of the peak for 1,3-butylene glycol. 1,3-Butylene glycol which, upon analysis by gas chromatography under specific conditions, gives a chromatogram in which the sum of the areas of the peaks attributable to 2- butoxy-6-methyl-4-tetrahydropyranols accounts for 0.025% or less of the area of the peak for 1,3-butylene glycol.
Patent CA-2467013-A1 (CA)
Title: Substituted benzopyrans as selective estrogen receptor-beta agonists
Inventor: NORMAN BRYAN HURST
IPC: A61P25/28
Filed: 2002-11-07
Abstract: The present invention relates to substituted benzopyran derivatives,stereoisomers, and pharmaceutical acceptable salts thereof and processes for the preparation of the same. The compounds of the present invention are useful as Estrogen Receptor .beta. agonists. Such agonists are useful for the treating Estrogen Receptor .beta. mediated diseases such as prostate cancer.
Patent CA-2467164-A1 (CA)
Inventor: CHEN XIAOXI KEVIN
IPC: B01L3/00
Filed: 2004-05-13
Abstract: The subject invention provides a sample processing technique for purifying a biological or chemical sample. The invention is particularly well-suited to prepare a sample for mass spectrometry. The process is to be performed in an article having at least one well, in which the surface of the well is at least partially hydrophobic and/or modified with bio-specific ligands. Targeted solutes, such as salts or small molecule contaminants, can be removed from a solution to allow for a purified solution of a desired type of solute, such as peptides and/or proteins.
Patent CA-2467663-A1 (CA)
Inventor: GOODIN RICHARD L
IPC: B29C65/00
Filed: 2003-01-08
Abstract: A catheter comprises a first component and a second component. The first component has a first outer diameter and the second component has a second outer diameter. At least a portion of the first component being bonded to at least a portion of the second component. When the at least a portion of the first component is bonded to the at least a portion of the second component the first outer diameter is substantially equal to the second outer diameter.  A heat shrink material being utilized to bond the at least a portion of the first component to the at least a portion of the second component.
Patent CA-2468658-A1 (CA)
Title: [1,2,4]-triazole bicyclic adenosine a2a receptor antagonists
Inventor: LIU HONG
IPC: C07D487/04
Filed: 2002-11-26
Abstract: Compounds having structural formula (I) wherein: n is 0, 1, 2 or 3; A is C(R1) or N; R1 and R1a are H, (C1-C6)-alkyl, halo, CN or -CF3; X is -C(O)-, -O-, -SO0-2-, or optionally substituted methylene, imino, arylene or heteroaryldiyl;  Y is -O-, -SO0-2-, or optionally substituted arylene, heteroaryldiyl, or nitrogen-containing heterocycloalkyl, or with certain provisos, a bond; R is optionally substituted aryl or heteroaryl; and R2 is optionally substituted aryl, heteroaryl, arylalkyl or heteroarylalkyl; or R2-Y is a fused piperidinyl, substituted piperazinyl or substituted piperidinyl; their use in the treatment of Parkinson's disease, alone or in combination with other agents for treating Parkinson's disease, pharmaceutical compositions comprising them and kits comprising the components of the combinations.
Patent CA-2468833-A1 (CA)
Title: (20s)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
Inventor: HOLDEN HAZEL M
IPC: A61P29/00
Filed: 2002-12-12
Abstract: This invention discloses (20S)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol, pharmaceutical uses therefor, and a method of purifying this compound to obtain it in crystalline form. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also has little, if any, calcemic activity and therefore may be used to treat immune disorders in humans as well as renal osteodystrophy.
Patent CA-2468988-A1 (CA)
Title: Hydrogel compositions comprising an acryloyl morpholine polymer
Inventor: HOSKINS RICHARD
IPC: A61F13/00
Filed: 2002-12-13
Abstract: The invention provides a hydrogel composition comprising a plasticised cross-linked hydrophilic polymer of acryloyl morpholine and optionally one or more comonomers.
Patent CA-2472302-A1 (CA)
Title: Improved park position locking system for automatic transmission shifter
Inventor: LINDSEY AARON D
IPC: F16H59/74
Filed: 2003-01-22
Abstract: A park position locking system controls the conditions for removing an automatic transmission gearshift (90) from a PARK position. An electronic system controller (30) and the transmission controller (16) are engaged to a common data bus (18). Vehicle control system (10) comprises the electronic system controller (ESC) (30), which is the primary component of a vehicle electronic control system. ESC (30) manages and communicates with a number of vocational controllers and executes a load management program which oversees the total load imposed on the vehicle electrical system and power train by various accessories by a standard communication protocol that may be the SAE  J1939 protocol over the common data bus (18). ESC (30) is programmed to ensure that an operator of the vehicle may not move the gearshift (90) out of a PARK  position without first depressing a service brake pedal. ESC (30) prevents or allows movement of the gearshift through a solenoid operated locking mechanism engaged to the gearshift (90).
Patent CA-2474037-A1 (CA)
Title: Shaft sealing system for a rotary mechanical device
Inventor: WILKINSON MARK R
IPC: F16J15/18
Filed: 2003-01-21
Abstract: A sealing system (2) to be inserted into the seal cavity of a rotary mechanical device to provide a seal and a bearing surface to eliminate whip in a rotating shaft (14). The scaling system (2) includes a split bushing element (31) to allow easy instal-lation over the shaft (14). The bushing (31) is substantially cylindrical with an inner bore closely approximating the outer diameter of the shaft and includes a groove (36) at the motor end on the outer surface and a corresponding groove (37) on the inner surface to provide a lantern ring. Seal water openings (38) are provided between the outer groove (36) and inner groove (37) of the bushing (31). Generally, two or three packing rings (32) are added on the motor side to complete the shaft sealing system (2) for installation in the seal cavity.
Patent CA-2475148-A1 (CA)
Title: Plate-forme inter-aubes a flechissement lateral, pour un support d'aubes de turboreacteur
Inventor: LEJARS CLAUDE ROBERT LOUIS
IPC: F01D5/30
Filed: 2004-07-23
Abstract: Une plate-forme inter-aubes (3), pour un disque de support d'aubes (1) d'une soufflante de turboréacteur, comprend une partie centrale (5) solidarisée au disque de support (1) entre deux aubes adjacentes (2), et deux parties latérales (8,9) prolongeant deux bords latéraux (6,7) de la partie centrale (5) et chacune agencée de manière à fléchir sous l'impact de l'aube (2) en regard de laquelle elle est placée.
Patent CA-2476165-A1 (CA)
Inventor: KINGSMAN SUSAN
IPC: C12N5/09
Filed: 2003-02-13
Abstract: There is provided an MHC class I peptide epitope from 5T4 antigen. In particular, there is provided a peptide epitope of 5T4 which comprises one of the following: (i) the amino acid sequence shown as SEQ ID No.2; (ii) the minimal epitope from the amino acid sequence shown as SEQ ID No.3; (iii) the minimal epitope from the amino acid sequence shown as SEQ ID No.4. (iv) the minimal epitope from the amino acid sequence shown as SEQ ID No. 5. (v) the minimal epitope from the amino acid sequence shown as SEQ ID No.6. (vi) the minimal epitope from the amino acid sequence shown as SEQ ID No.7. There is also provided a vaccine comprising such a peptide (or precursor thereof) and its use to treat and/or prevent a disease, in particular a cancerous disease.
Patent CA-2476873-A1 (CA)
Title: Ultrasonic treatment and imaging of adipose tissue
Inventor: HENNIGE CARL
IPC: A61B8/00
Filed: 2003-02-20
Abstract: A system for the destruction of adipose tissue utilizing high intensity focused ultrasound (HIFU) within a patient's body. The system comprises a controller for data storage and the operation and control of a plurality of elements. One elements is a means for mapping a human body to establish thre e dimensional coordinate position data for existing adipose tissue. The controller is able to identify the plurality of adipose tissue locations on said human body and establish a protocol for the destruction of the adipose tissue. A HIFU transducer assembly having one or more piezoelectric element( s) (21) is used along with at least one sensor wherein the sensor provides feed back information to the controller for the safe operation of the piezoelectr ic element(s) (21). The sensor is electronically coupled to the controller, and the controller provides essential treatment command information to one or mo re piezoelectric element(s) based on positioning information obtained from the three dimensional coordinate position data.